Actively Recruiting
Study of Diabetic Retinopathy Rates and Risk Factors in Adults with Diabetes at a Hospital in Central Vietnam
Led by Da Nang Family General Hospital · Updated on 2026-03-12
300
Participants Needed
1
Research Sites
2 weeks
Total Duration
AI-Summary
What this Trial Is About
Diabetic retinopathy DR is a common cause of preventable vision loss globally, affecting about 22-26% of people with diabetes, with vision-threatening cases in about 6%. This research aims to determine the local prevalence, severity, and risk factors of DR among diabetic patients at Gia Dinh Family Hospital in Da Nang, Vietnam. Understanding these factors is important to improve screening and management to reduce vision loss in this population. The study observes diabetic patients who have undergone eye examinations including dilated fundus examination and optical coherence tomography OCT during the period from January to September 2025. These patients are identified through the hospitals electronic health records. No treatments are given the study collects and reviews clinical and laboratory data from medical records to analyze DR prevalence and associated risk factors. Participants will have had their eye exams and medical records reviewed for diabetes diagnosis and key health information. Researchers will measure how common DR is, at what stages it occurs, and which health factors are linked to DR presence. The main outcome is the prevalence of any stage of DR at baseline. The study will conclude by March 2026, with data collected retrospectively from the 2025 study period.
CONDITIONS
Brief Title
Diabetic Retinopathy Prevalence And Risk Factors
Research Team
T
Thảo Nguyễn, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here